AI Engines For more Details: Perplexity Kagi Labs You
Pain Relief: Oxaprozin is primarily used to relieve mild to moderate pain, including pain caused by conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and juvenile rheumatoid arthritis. It helps reduce inflammation, swelling, stiffness, and joint pain.
Anti-inflammatory Effects: Like other NSAIDs, oxaprozin works by inhibiting the production of prostaglandins, which are substances in the body that contribute to inflammation and pain. By reducing inflammation, oxaprozin helps alleviate symptoms associated with inflammatory conditions.
Musculoskeletal Disorders: Oxaprozin is effective in providing symptomatic relief for musculoskeletal disorders characterized by inflammation, such as tendonitis, bursitis, and sprains.
Dosage and Administration: Oxaprozin is typically taken orally, usually once or twice daily with food or milk to minimize gastrointestinal side effects. The dosage and duration of treatment depend on the individual's medical condition and response to therapy.
Long-term Use: Oxaprozin is usually prescribed for short-term use to relieve acute pain or for extended periods to manage chronic inflammatory conditions like arthritis. However, prolonged use of NSAIDs, including oxaprozin, may increase the risk of adverse effects.
Side Effects: Common side effects of oxaprozin may include gastrointestinal symptoms such as stomach pain, heartburn, nausea, vomiting, diarrhea, and constipation. It may also cause dizziness, headache, drowsiness, fluid retention, elevated blood pressure, and allergic reactions in some individuals.
Cardiovascular Risks: NSAIDs, including oxaprozin, may increase the risk of cardiovascular events such as heart attack and stroke, particularly when used at high doses or for long durations. This risk may be higher in individuals with pre-existing cardiovascular conditions or those taking other medications that affect blood clotting.
Gastrointestinal Risks: Oxaprozin can cause gastrointestinal ulcers, bleeding, and perforation, which may be severe and potentially life-threatening. Older adults and individuals with a history of peptic ulcers, gastrointestinal bleeding, or other gastrointestinal disorders are at higher risk.
Kidney and Liver Effects: Prolonged use of oxaprozin may lead to kidney damage, reduced kidney function, or acute kidney injury, especially in susceptible individuals. It may also cause liver toxicity or worsen pre-existing liver conditions.
Drug Interactions: Oxaprozin may interact with other medications, including anticoagulants, antiplatelet drugs, corticosteroids, selective serotonin reuptake inhibitors (SSRIs), and certain blood pressure medications. These interactions can increase the risk of bleeding, gastrointestinal complications, or other adverse effects.
Contraindications: Oxaprozin is contraindicated in individuals with a history of hypersensitivity reactions to NSAIDs, aspirin-sensitive asthma, peptic ulcer disease, severe kidney impairment, and active gastrointestinal bleeding.
Pregnancy and Lactation: NSAIDs, including oxaprozin, should be avoided during the third trimester of pregnancy due to the risk of fetal harm and complications during delivery. They may also pass into breast milk and affect nursing infants, so caution is advised while breastfeeding.
Monitoring: Regular monitoring of renal function, liver function, and blood pressure may be recommended during long-term treatment with oxaprozin to detect any potential adverse effects.
Rank | Probiotic | Impact |
---|---|---|
genus | Bacillus | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Chordicoccus | genus | Decreases |
0 | 1 | Intestinibaculum | genus | Decreases |
0 | 1 | Oscillibacter | genus | Decreases |
0 | 1 | Mageeibacillus | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Faecalibacillus | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Monoglobus | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Adlercreutzia | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Faecalitalea | genus | Decreases |
0 | 1 | Acutalibacter | genus | Decreases |
0 | 1 | Lactococcus | genus | Decreases |
0 | 1 | Komagataeibacter | genus | Decreases |
0 | 1 | Christensenella | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Maliibacterium | genus | Decreases |
0 | 1 | Massilistercora | genus | Decreases |
0 | 1 | Fannyhessea | genus | Decreases |
0 | 1 | Novisyntrophococcus | genus | Decreases |
0 | 1 | Faecalibaculum | genus | Decreases |
0 | 1 | Treponema | genus | Decreases |
0 | 1 | Qiania | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Olsenella | genus | Decreases |
0 | 1 | Bacillus | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Vescimonas | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Faecalibacterium | genus | Decreases |
0 | 1 | Parvimonas | genus | Decreases |
0 | 1 | Marvinbryantia | genus | Decreases |
0 | 1 | Turicibacter | genus | Decreases |
0 | 1 | Aminipila | genus | Decreases |
0 | 1 | Lawsonibacter | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Lachnospira eligens | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Clostridioides difficile | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.5 | 0.5 | |
ADHD | 0.5 | 1.4 | -1.8 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0.5 | |
Allergic Rhinitis (Hay Fever) | 1.2 | 0.7 | 0.71 |
Allergies | 2.7 | 1.6 | 0.69 |
Allergy to milk products | 1.7 | 0.6 | 1.83 |
Alopecia (Hair Loss) | 0.4 | 0.2 | 1 |
Alzheimer's disease | 2.8 | 4.1 | -0.46 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.2 | 0.7 | 0.71 |
Ankylosing spondylitis | 1.4 | 0.8 | 0.75 |
Anorexia Nervosa | 0.5 | 1.2 | -1.4 |
Antiphospholipid syndrome (APS) | 0.4 | 0.3 | 0.33 |
Asthma | 1.4 | 0.5 | 1.8 |
Atherosclerosis | 0.9 | 0.9 | 0 |
Atrial fibrillation | 1.2 | 1.7 | -0.42 |
Autism | 4.5 | 3.7 | 0.22 |
Autoimmune Disease | 0.1 | 0.6 | -5 |
benign prostatic hyperplasia | 0.1 | 0.1 | 0 |
Biofilm | 0.5 | 0.5 | |
Bipolar Disorder | 1.3 | 1 | 0.3 |
Brain Trauma | 0.3 | 0.8 | -1.67 |
Breast Cancer | 0.2 | 0.2 | |
Cancer (General) | 1.4 | -1.4 | |
Carcinoma | 1.9 | 1.1 | 0.73 |
Celiac Disease | 0.6 | 1.1 | -0.83 |
Cerebral Palsy | 0.5 | 0.4 | 0.25 |
Chronic Fatigue Syndrome | 2.5 | 4 | -0.6 |
Chronic Kidney Disease | 1.8 | 2.2 | -0.22 |
Chronic Lyme | 0.1 | 0.1 | 0 |
Chronic Obstructive Pulmonary Disease (COPD) | 1 | 1.1 | -0.1 |
Chronic Urticaria (Hives) | 0.7 | 0.6 | 0.17 |
Coagulation / Micro clot triggering bacteria | 0.6 | 1 | -0.67 |
Cognitive Function | 1 | 0.9 | 0.11 |
Colorectal Cancer | 2.2 | 1.2 | 0.83 |
Constipation | 0.4 | 0.3 | 0.33 |
Coronary artery disease | 1.6 | 2.1 | -0.31 |
COVID-19 | 2.5 | 5.7 | -1.28 |
Crohn's Disease | 3.9 | 3.5 | 0.11 |
cystic fibrosis | 0.4 | 0.3 | 0.33 |
d-lactic acidosis (one form of brain fog) | 0.2 | 0.2 | |
deep vein thrombosis | 1 | 1 | 0 |
Denture Wearers Oral Shifts | 0.1 | 0.1 | |
Depression | 4.7 | 4.9 | -0.04 |
Eczema | 0.9 | 0.5 | 0.8 |
Endometriosis | 1.4 | 1.3 | 0.08 |
Eosinophilic Esophagitis | 0.1 | -0.1 | |
Epilepsy | 1.5 | 0.3 | 4 |
erectile dysfunction | 0.6 | 0.1 | 5 |
Fibromyalgia | 0.8 | 1.9 | -1.37 |
Functional constipation / chronic idiopathic constipation | 2.5 | 2.5 | 0 |
gallstone disease (gsd) | 1.5 | 0.5 | 2 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.1 | -1.1 | |
Generalized anxiety disorder | 1.2 | 1.1 | 0.09 |
giant cell arteritis | 0.3 | -0.3 | |
Glioblastoma | 0.2 | 0.1 | 1 |
Gout | 0.2 | 0.8 | -3 |
Graves' disease | 0.2 | 0.6 | -2 |
Gulf War Syndrome | 0.8 | 0.8 | |
Halitosis | 0.4 | 0.4 | |
Hashimoto's thyroiditis | 1.3 | 0.9 | 0.44 |
Heart Failure | 2.5 | 1.6 | 0.56 |
hemorrhagic stroke | 0.3 | 0.3 | |
Hidradenitis Suppurativa | 0.5 | 0.5 | |
High Histamine/low DAO | 1.4 | 0.3 | 3.67 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.3 | 1 |
hyperglycemia | 0.6 | 0.6 | |
Hyperlipidemia (High Blood Fats) | 0.7 | 0.1 | 6 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 1.8 | 2.7 | -0.5 |
Hypothyroidism | 0.2 | 1 | -4 |
Hypoxia | 1.3 | 1.3 | |
IgA nephropathy (IgAN) | 0.4 | 2 | -4 |
Inflammatory Bowel Disease | 3.5 | 4.9 | -0.4 |
Insomnia | 1.3 | 0.8 | 0.63 |
Intelligence | 1.1 | 1 | 0.1 |
Intracranial aneurysms | 0.3 | 0.8 | -1.67 |
Irritable Bowel Syndrome | 2.6 | 2.2 | 0.18 |
ischemic stroke | 0.4 | 0.7 | -0.75 |
Juvenile idiopathic arthritis | 0.1 | 0.2 | -1 |
Liver Cirrhosis | 3.5 | 3 | 0.17 |
Long COVID | 3.2 | 3.9 | -0.22 |
Low bone mineral density | 0.1 | 1.3 | -12 |
Lung Cancer | 0.4 | 0.6 | -0.5 |
Lymphoma | 0.1 | 0.1 | 0 |
Mast Cell Issues / mastitis | 0.1 | 0.7 | -6 |
ME/CFS with IBS | 0.5 | 2.4 | -3.8 |
ME/CFS without IBS | 1.3 | 0.8 | 0.63 |
Menopause | 0.3 | 0.4 | -0.33 |
Metabolic Syndrome | 4.6 | 3.8 | 0.21 |
Mood Disorders | 5 | 3.8 | 0.32 |
Multiple Sclerosis | 2.1 | 3.8 | -0.81 |
Multiple system atrophy (MSA) | 0.2 | 0.2 | 0 |
myasthenia gravis | 0.2 | 0.7 | -2.5 |
neuropathic pain | 0.1 | 0.5 | -4 |
Neuropathy (all types) | 0.2 | 0.3 | -0.5 |
neuropsychiatric disorders (PANDAS, PANS) | 0.2 | 0.2 | 0 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.6 | 2.8 | -0.08 |
NonCeliac Gluten Sensitivity | 0.1 | 0.1 | 0 |
Obesity | 5.9 | 4.6 | 0.28 |
obsessive-compulsive disorder | 1.7 | 2.2 | -0.29 |
Osteoarthritis | 1.4 | 0.7 | 1 |
Osteoporosis | 1 | 0.5 | 1 |
Parkinson's Disease | 3.8 | 4.4 | -0.16 |
Polycystic ovary syndrome | 2.4 | 1 | 1.4 |
Postural orthostatic tachycardia syndrome | 0.3 | 0.5 | -0.67 |
primary biliary cholangitis | 0.3 | 0.4 | -0.33 |
Primary sclerosing cholangitis | 0.5 | 2.3 | -3.6 |
Psoriasis | 1.2 | 1.8 | -0.5 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.8 | 2 | 0.9 |
Rosacea | 0.5 | 0.5 | 0 |
Schizophrenia | 2.9 | 1.8 | 0.61 |
scoliosis | 1.2 | 0.6 | 1 |
sensorineural hearing loss | 0.5 | 0.5 | |
Sjögren syndrome | 0.9 | 0.5 | 0.8 |
Sleep Apnea | 1.1 | 0.9 | 0.22 |
Slow gastric motility / Gastroparesis | 0.6 | 0.1 | 5 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.3 | 1.3 | |
Stress / posttraumatic stress disorder | 1.1 | 1.1 | 0 |
Systemic Lupus Erythematosus | 1.9 | 1 | 0.9 |
Tic Disorder | 0.3 | 1.5 | -4 |
Tourette syndrome | 0.1 | 0.1 | |
Type 1 Diabetes | 1.6 | 1.5 | 0.07 |
Type 2 Diabetes | 4.1 | 3.1 | 0.32 |
Ulcerative colitis | 3.2 | 3.4 | -0.06 |
Unhealthy Ageing | 1.8 | 1.3 | 0.38 |
Vitiligo | 0.7 | 1 | -0.43 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]